DNDi, GSK, and University of Dundee to identify drug candidates to treat leishmaniasis and Chagas

(Drugs for Neglected Diseases Initiative) The not-for-profit research and development organization Drugs for Neglected Diseases initiative (DNDi) will collaborate with GlaxoSmithKline (GSK), and the University of Dundee Drug Discovery Unit (DDU), in a bid to discover new pre-clinical drug candidates targeting two parasitic neglected tropical diseases (NTDs), leishmaniasis and Chagas disease.